pubmed-article:8998140 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:8998140 | lifeskim:mentions | umls-concept:C0030567 | lld:lifeskim |
pubmed-article:8998140 | lifeskim:mentions | umls-concept:C0011923 | lld:lifeskim |
pubmed-article:8998140 | lifeskim:mentions | umls-concept:C0114838 | lld:lifeskim |
pubmed-article:8998140 | lifeskim:mentions | umls-concept:C0040399 | lld:lifeskim |
pubmed-article:8998140 | pubmed:issue | 1 | lld:pubmed |
pubmed-article:8998140 | pubmed:dateCreated | 1997-2-11 | lld:pubmed |
pubmed-article:8998140 | pubmed:abstractText | The aim of the present study was to demonstrate the degeneration of the dopaminergic nigrostriatal pathway in Parkinson's disease by using the cocaine derivative [123I]beta-CIT (2-beta-carbomethoxy-3-beta(4-iodophenyl)-tropane or RTI-55) and SPECT and to relate the findings to the severity of the disease (Hoehn and Yahr scale, H/Y) and to clinical data such as motor score and activities of daily living. | lld:pubmed |
pubmed-article:8998140 | pubmed:language | eng | lld:pubmed |
pubmed-article:8998140 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8998140 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:8998140 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8998140 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8998140 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8998140 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8998140 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8998140 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8998140 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8998140 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8998140 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8998140 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:8998140 | pubmed:month | Jan | lld:pubmed |
pubmed-article:8998140 | pubmed:issn | 0161-5505 | lld:pubmed |
pubmed-article:8998140 | pubmed:author | pubmed-author:DeeckeLL | lld:pubmed |
pubmed-article:8998140 | pubmed:author | pubmed-author:BrückeTT | lld:pubmed |
pubmed-article:8998140 | pubmed:author | pubmed-author:AngelbergerPP | lld:pubmed |
pubmed-article:8998140 | pubmed:author | pubmed-author:MüllerCC | lld:pubmed |
pubmed-article:8998140 | pubmed:author | pubmed-author:PodrekaII | lld:pubmed |
pubmed-article:8998140 | pubmed:author | pubmed-author:WöberCC | lld:pubmed |
pubmed-article:8998140 | pubmed:author | pubmed-author:WengerSS | lld:pubmed |
pubmed-article:8998140 | pubmed:author | pubmed-author:AsenbaumSS | lld:pubmed |
pubmed-article:8998140 | pubmed:author | pubmed-author:PirkerWW | lld:pubmed |
pubmed-article:8998140 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:8998140 | pubmed:volume | 38 | lld:pubmed |
pubmed-article:8998140 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:8998140 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:8998140 | pubmed:pagination | 1-6 | lld:pubmed |
pubmed-article:8998140 | pubmed:dateRevised | 2005-11-17 | lld:pubmed |
pubmed-article:8998140 | pubmed:meshHeading | pubmed-meshheading:8998140-... | lld:pubmed |
pubmed-article:8998140 | pubmed:meshHeading | pubmed-meshheading:8998140-... | lld:pubmed |
pubmed-article:8998140 | pubmed:meshHeading | pubmed-meshheading:8998140-... | lld:pubmed |
pubmed-article:8998140 | pubmed:meshHeading | pubmed-meshheading:8998140-... | lld:pubmed |
pubmed-article:8998140 | pubmed:meshHeading | pubmed-meshheading:8998140-... | lld:pubmed |
pubmed-article:8998140 | pubmed:meshHeading | pubmed-meshheading:8998140-... | lld:pubmed |
pubmed-article:8998140 | pubmed:meshHeading | pubmed-meshheading:8998140-... | lld:pubmed |
pubmed-article:8998140 | pubmed:meshHeading | pubmed-meshheading:8998140-... | lld:pubmed |
pubmed-article:8998140 | pubmed:meshHeading | pubmed-meshheading:8998140-... | lld:pubmed |
pubmed-article:8998140 | pubmed:meshHeading | pubmed-meshheading:8998140-... | lld:pubmed |
pubmed-article:8998140 | pubmed:meshHeading | pubmed-meshheading:8998140-... | lld:pubmed |
pubmed-article:8998140 | pubmed:meshHeading | pubmed-meshheading:8998140-... | lld:pubmed |
pubmed-article:8998140 | pubmed:meshHeading | pubmed-meshheading:8998140-... | lld:pubmed |
pubmed-article:8998140 | pubmed:meshHeading | pubmed-meshheading:8998140-... | lld:pubmed |
pubmed-article:8998140 | pubmed:meshHeading | pubmed-meshheading:8998140-... | lld:pubmed |
pubmed-article:8998140 | pubmed:meshHeading | pubmed-meshheading:8998140-... | lld:pubmed |
pubmed-article:8998140 | pubmed:meshHeading | pubmed-meshheading:8998140-... | lld:pubmed |
pubmed-article:8998140 | pubmed:year | 1997 | lld:pubmed |
pubmed-article:8998140 | pubmed:articleTitle | Imaging of dopamine transporters with iodine-123-beta-CIT and SPECT in Parkinson's disease. | lld:pubmed |
pubmed-article:8998140 | pubmed:affiliation | Department of Neurology, University of Vienna, Austria. | lld:pubmed |
pubmed-article:8998140 | pubmed:publicationType | Journal Article | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8998140 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8998140 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8998140 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8998140 | lld:pubmed |